In the present study, we provided new evidence that miR-192-5p was involved in the pathogenesis of NAFLD and that it regulated hepatic lipogenesis by targeting the YY1/FASN pathway. Here, YY1 is linked to metabolic dysfunction-associated steatotic liver disease.